357.42
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $357.42, with a volume of 86,833.
It is up +1.89% in the last 24 hours and down -2.37% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$348.79
Open:
$350.89
24h Volume:
86,833
Relative Volume:
0.05
Market Cap:
$136.72B
Revenue:
$24.38B
Net Income/Loss:
$2.94B
P/E Ratio:
46.93
EPS:
7.6159
Net Cash Flow:
$4.07B
1W Performance:
+0.36%
1M Performance:
-2.37%
6M Performance:
-10.09%
1Y Performance:
-1.65%
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SYK
Stryker Corp
|
357.50 | 133.39B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
ABT
Abbott Laboratories
|
128.85 | 219.88B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
96.69 | 141.54B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
MDT
Medtronic Plc
|
100.06 | 124.82B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
86.07 | 48.84B | 5.88B | 1.34B | 799.60M | 2.3489 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-19-25 | Upgrade | Citizens JMP | Mkt Perform → Mkt Outperform |
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
Stryker Corporation $SYK Shares Sold by Greenleaf Trust - MarketBeat
Stryker's (NYSE:SYK) investors will be pleased with their notable 54% return over the last five years - simplywall.st
Stryker to Release Fourth Quarter and Full Year 2025 Financial Results on January 29, 2026 - Quiver Quantitative
Stryker to announce financial results for its fourth quarter and full year 2025 - GlobeNewswire Inc.
Medical Sales Rep Salary Stryker Resentative Actual 2023 Projected 2024- - shababeek.org
Stryker Corp. stock: quiet chart, firm pulse – is this medtech leader still a buy after its latest run? - AD HOC NEWS
Stryker Corporation $SYK Shares Sold by Banque Pictet & Cie SA - MarketBeat
Stryker Corp. stock: steady climb, cautious optimism as Wall Street eyes medtech resilience - AD HOC NEWS
List of 54 Acquisitions by Stryker (Jan 2026) - Tracxn
Ascent Group LLC Increases Stake in Stryker Corporation $SYK - MarketBeat
P/E Ratio Insights for Stryker - Benzinga
Diversified Trust Co Increases Stock Holdings in Stryker Corporation $SYK - MarketBeat
Stryker stock slips today as year-end trading turns cautious — dividend date and new COO in focus - ts2.tech
Ex-Dividend Reminder: National Healthcare, Stryker and Annaly Capital Management - Nasdaq
Norris Perne & French LLP MI Has $16.69 Million Stock Holdings in Stryker Corporation $SYK - MarketBeat
Stryker Corporation $SYK Stock Position Decreased by Ethic Inc. - MarketBeat
Boston Trust Walden Corp Reduces Position in Stryker Corporation $SYK - MarketBeat
Valley National Advisers Inc. Raises Stock Holdings in Stryker Corporation $SYK - MarketBeat
NovaPoint Capital LLC Invests $1.06 Million in Stryker Corporation $SYK - MarketBeat
A Look At The Fair Value Of Stryker Corporation (NYSE:SYK) - 富途牛牛
Highland Capital Management LLC Buys Shares of 5,828 Stryker Corporation $SYK - MarketBeat
Carnegie Investment Counsel Grows Position in Stryker Corporation $SYK - MarketBeat
Mirabaud & Cie SA Has $712,000 Holdings in Stryker Corporation $SYK - MarketBeat
Stryker Earnings Preview: What to Expect - Barchart.com
Private Trust Co. NA Boosts Stock Position in Stryker Corporation $SYK - MarketBeat
How Investors May Respond To Stryker (SYK) Dividend Hike and Leadership Reshuffle - simplywall.st
Stryker Stock (SYK) After the Bell on Dec. 24, 2025: Latest News, Forecasts, and What to Watch Before the Next Market Open - ts2.tech
Intuitive Surgical vs. Stryker: Which MedTech Stock Has More Upside? - Nasdaq
Citi Cuts Stryker (SYK) PT, Maintains Buy Amid Leadership Changes - Finviz
Corsicana & Co. Acquires New Position in Stryker Corporation $SYK - MarketBeat
Stryker Corporation $SYK Shares Bought by Cyndeo Wealth Partners LLC - MarketBeat
Stryker (SYK): Reassessing Valuation After Dividend Hike and Parnassus Endorsement - simplywall.st
Tech Rally: Is Stryker Corporation stock inflation resilientWeekly Market Summary & Free Community Supported Trade Ideas - Улправда
Why Analysts Think Stryker’s Story Is Shifting As Valuation Gets More Sensitive To Growth - Yahoo Finance
Is It Too Late To Consider Stryker After Its Robotics Expansion And Strong Share Gains? - simplywall.st
Citizens JMP Upgrades Stryker Corp(SYK.US) to Buy Rating, Announces Target Price $440 - 富途牛牛
Stryker upgraded on strong execution and room for rebound - Investing.com
SYK: Stryker Receives Upgrade to Market Outperform by Citizens T - GuruFocus
Citizens Jmp Upgrades Stryker (NYSE:SYK) to Outperform - MarketBeat
Here Are Friday’s Top Wall Street Analyst Research Calls: Birkenstock, Coreweave, Lockheed Martin, Lyft, Paccar, Stryker, Synaptics, and More - 24/7 Wall St.
How Stryker Corporation stock performs in weak economy2025 Volume Leaders & Low Volatility Stock Suggestions - Bölüm Sonu Canavarı
Is Stryker Corporation stock a buy for dividend growthJuly 2025 Highlights & Low Risk Profit Maximizing Plans - DonanımHaber
Addenda Capital Inc. Increases Holdings in Stryker Corporation $SYK - MarketBeat
Citizens upgrades Stryker stock rating to Market Outperform on valuation - Investing.com
Will Stryker Corporation stock maintain momentum in 2025July 2025 Breakouts & Daily Profit Focused Stock Screening - Улправда
Truist Financial Maintains Stryker Corp(SYK.US) With Hold Rating, Announces Target Price $392 - 富途牛牛
What Makes Stryker Corp. (SYK) a High-Quality, Defensive Compounder? - Finviz
Truist Financial Has Lowered Expectations for Stryker (NYSE:SYK) Stock Price - MarketBeat
What makes Stryker Corp. (SYK) a high-quality, defensive compounder? - MSN
Why Stryker (SYK) is a Top Growth Stock for the Long-Term - Yahoo Finance
Aug Outlook: How interest rate cuts could boost Stryker Corporation stock2025 Analyst Calls & Short-Term High Return Ideas - Улправда
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):